Literature DB >> 1949076

Accumulation of phenols in isolated hepatocytes after pretreatment with methylglyoxal.

M P Kalapos1, Z Schaff, T Garzó, F Antoni, J Mandl.   

Abstract

The effects of a single intraperitoneal injection of methylglyoxal (50-800 mg/kg body wt.) in mice were investigated in the liver after 24 h. The administration of methylglyoxal (400 mg/kg body wt.) resulted in an increase in aniline hydroxylase activity in liver microsomes. At the same time an accumulation of p-amino-phenol, the hydroxylated product of aniline, was observed in isolated hepatocytes upon addition of aniline similarly to conditions (starvation, diabetes mellitus, pyrazole pretreatment) when aniline hydroxylase was induced. Methylglyoxal also decreased the reduced glutathione content in the liver, while the activity of serum glutamate pyruvate transaminase was increased, suggesting the onset of liver injuries. It is assumed that the increased oxidation of aniline hydroxylase combined with decreased glutathione levels after methylglyoxal treatment favours the formation of potentially hazardous phenol derivatives in the liver.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949076     DOI: 10.1016/0378-4274(91)90172-3

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  3 in total

1.  Glucose formation from methylglyoxal in hepatocytes from streptozotocin-induced diabetic mice: the effect of insulin.

Authors:  M P Kalapos; P Riba; T Garzo; J Mandl
Journal:  Experientia       Date:  1996-08-15

2.  Growth of Bradyrhizobium sp. SEMIA 6144 in response to methylglyoxal: role of glutathione.

Authors:  E Bianucci; A Fabra; S Castro
Journal:  Curr Microbiol       Date:  2008-01-08       Impact factor: 2.188

3.  Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions.

Authors:  Waseem Hassan; Carlos Eduardo Barroso Silva; Imdad Ullah Mohammadzai; Joao Batista Teixeira da Rocha; Landeira-Fernandez J
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.